Capstan Medical
Capstan Medical is a Santa Cruz, California medical device company founded in 2020 out of the Occam Labs incubator by Dan Wallace, with Maggie Nixon as CEO. The company is developing a surgical robotics platform for structural heart disease, merging robotic catheter navigation with next-generation transcatheter mitral and tricuspid valve implants so heart valves can be repaired or replaced without open heart surgery. In 2025 Capstan completed what it describes as the world's first robotic catheter mitral valve replacements in humans, and it raised a $110M Series C led by Eclipse with participation from Intuitive Ventures and Yu Galaxy, bringing total funding past $150M ahead of a second-generation system planned for 2026. Capstan is pre-commercial and regulated medical device focused: it publishes no public developer portal, API documentation, SDKs, or machine-readable API contracts.
Capstan Medical is profiled on the APIs.io network. Tagged areas include Company, Medical Devices, Surgical Robotics, Structural Heart, and Cardiovascular.
Capstan Medical’s developer surface includes engineering blog, support, and 12 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Build 1
SDKs, sample code, and the tooling you integrate with
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 6
The organization behind the API
Other 2
Properties that don't map to a standard resource type